Published Research
Published Research
3 results for Dana-Farber Cancer Institute
Next-Gen Cell Therapies
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial
September 4, 2026Dana-Farber Cancer Institute, University of Pennsylvania, University of California, Los Angeles, University of California, San Francisco, University of Texas, MD Anderson Cancer Center
Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial
January 29, 2026Dana-Farber Cancer Institute, University of California, Los Angeles, University of Southern California, University of Texas, MD Anderson Cancer Center
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
October 17, 2019Dana-Farber Cancer Institute